| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |